ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,709Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 670

$931K Total Retail Price of All Prescriptions

Rank: 46 out of 670

636 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 15,563 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 893 779 1 4
LISINOPRIL 810 730 2 3
OMEPRAZOLE 673 585 3 5
METFORMIN HCL 575 503 4 8
LEVOTHYROXINE SODIUM 568 522 5 2
FUROSEMIDE 511 453 6 6
AMLODIPINE BESYLATE 484 410 7 7
HYDROCODONE-ACETAMINOPHEN 405 329 S3 8 1
POTASSIUM CHLORIDE 394 357 9 16
HYDROCHLOROTHIAZIDE 363 311 10 10
SERTRALINE HCL 301 270 11 22
ATORVASTATIN CALCIUM 283 251 12 15
METOPROLOL TARTRATE 283 258 12 9
ATENOLOL 275 262 14 17
PRAVASTATIN SODIUM 269 250 15 19
METOPROLOL SUCCINATE 252 213 16 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 204 186 17 27
TAMSULOSIN HCL 198 191 18 30
WARFARIN SODIUM 193 166 19 13
DONEPEZIL HCL 180 180 20 31
ZOLPIDEM TARTRATE 179 119 21 23
SYNTHROID 177 159 22 47
NEXIUM 167 152 23 14
GABAPENTIN 158 122 24 11
AZITHROMYCIN 156 137 25 35
ISOSORBIDE MONONITRATE ER 154 127 26 45
AMLODIPINE BESYLATE-BENAZEPRIL 154 144 26 74
JANTOVEN 154 154 26 195
CITALOPRAM HBR 147 121 29 20
CRESTOR 145 124 30 18
DIGOXIN 117 116 31 46
ZETIA 116 109 32 66
ALENDRONATE SODIUM 114 108 33 43
ALLOPURINOL 112 106 34 38
GLIPIZIDE 108 105 35 67
PANTOPRAZOLE SODIUM 107 95 36 41
NAMENDA 106 106 37 54
MELOXICAM 106 80 37 33
JANUVIA 105 98 39 53
CLONIDINE HCL 104 104 40 62
DIOVAN 102 101 41 48
FAMOTIDINE 101 92 42 99
METHYLPREDNISOLONE 96 85 43 120
CLOPIDOGREL 86 74 44 24
DILTIAZEM 24HR ER 85 85 45 122
GLIMEPIRIDE 83 83 46 32
QUETIAPINE FUMARATE 79 75 47 84
FLUOXETINE HCL 79 55 47 55
CYMBALTA 76 47 49 36
FLUTICASONE PROPIONATE 74 68 50 37
RANITIDINE HCL 74 62 50 25
FENOFIBRATE 73 63 52 64
DIOVAN HCT 72 60 53 126
PREDNISONE 70 69 54 40
MIRTAZAPINE 70 57 54 59
OXYCODONE HCL-ACETAMINOPHEN 68 60 S2 56 71
CARVEDILOL 67 67 57 29
TRAMADOL HCL 67 59 57 21
LOSARTAN-HYDROCHLOROTHIAZIDE 66 66 59 73
FENTANYL 66 42 S2 59 76
FELODIPINE ER 66 64 59 144
FINASTERIDE 62 62 62 118
TRICOR 61 44 63 83
QUINAPRIL HCL 59 49 64 103
AMOXICILLIN 59 46 64 91
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 54 64 93
BENAZEPRIL HCL 59 48 64 90
LOVAZA 58 54 68 108
PRAMIPEXOLE DIHYDROCHLORIDE 58 58 68 198
CARBIDOPA-LEVODOPA 58 58 68 101
VENLAFAXINE HCL ER 57 40 71 97
KLOR-CON M20 56 54 72 57
PLAVIX 56 50 72 34
METFORMIN HCL ER 55 50 74 63
CIPROFLOXACIN HCL 55 52 74 60
LOVASTATIN 54 52 76 44
ESCITALOPRAM OXALATE 54 47 76 78
ACTOS 53 43 78 105
CHLORTHALIDONE 51 50 79 240
PROAIR HFA 51 45 79 28
NAPROXEN 51 39 79 81
KLOR-CON 10 51 49 79 166
ZOSTAVAX 51 48 79 194
LOSARTAN POTASSIUM 50 50 84 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.